Nature, Published online: 07 October 2026; doi:10.1038/s41586-026-11066-6

An effector regulatory T cell circuit is identified that can be monitored in blood samples to track the development of lung cancer, and blockade of this immune network in the preinvasive setting can intercept tumorigenesis to reduce tumour incidence and size.